Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation implications for transitions of care

Circulation: Cardiovascular Quality and Outcomes

Volumn 3, Issue 3, 2010, Pages 261-266

  Ho, P Michael ^a,b,c   Tsai, Thomas T ^a,b,c   Maddox, Thomas M ^a,b,c   Powers, J David ^a   Carroll, Nikki M ^a   Jackevicius, Cynthia ^d,e,f,g   Go, Alan S ^h,i   Margolis, Karen L ^j   Defor, Terese A ^j   Rumsfeld, John S ^a,b,c   Magid, David J ^a,c  

^a KAISER PERMANENTE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^g WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^h DIVISION OF RESEARCH   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

more..

Author keywords

Drugs; Epidemiology; Stents

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE; ANTITHROMBOCYTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION; ADJUVANT CHEMOTHERAPY; ANALOGS AND DERIVATIVES; CARDIOVASCULAR DISEASES; FOLLOW UP; MEDICATION THERAPY MANAGEMENT; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATION; PROSTHESIS IMPLANTATION; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURVIVAL; UNITED STATES;

CARDIOVASCULAR DISEASES; CHEMOTHERAPY, ADJUVANT; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; MYOCARDIAL INFARCTION; PATIENT COMPLIANCE; PATIENT DISCHARGE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PRESCRIPTIONS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TICLOPIDINE; UNITED STATES;

EID: 77953431835     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.109.902031     Document Type: Article

References (17)

1. Coleman EA, Smith JD, Raha D, Min SJ. Posthospital medication discrepancies: prevalence and contributing factors. Arch Intern Med. 2005;165:1842-1847.
2. Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117:1028-1036.
3. Ho PM, Spertus JA, Masoudi FA, Reid KJ, Peterson ED, Magid DJ, Krumholz HM, Rumsfeld JS. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med. 2006;166:1842-1847.
4. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS, Messenger JC, Khanal S, Peterson ED, Bach RG, Krumholz HM, Cohen DJ. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation. 2006;113:2803-2809.
5. Machecourt J, Danchin N, Lablanche JM, Fauvel JM, Bonnet JL, Marliere S, Foote A, Quesada JL, Eltchaninoff H, Vanzetto G; EVASTENT Investigators. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry. J Am Coll Cardiol. 2007;50:501-508.
6. Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, Dauerman HL, Ryan TJ Jr, Kiernan FJ, Cutlip DE, Ho KK, Gibson CM, Murphy SA, Cohen DJ. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Am Heart J. 2008;155:654-660.
7. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.
8. National Cardiovascular Data Registry website. Available at: http://www.ncdr.com/webncdr/common/. Accessed February 20, 2009.
9. Sheehy O, LeLorier J, Rinfret S. Restrictive access to clopidogrel and mortality following coronary stent implantation. CMAJ. 2008;178:413-420.
10. Jackevicius CA, Tu JV, Demers V, Melo M, Cox J, Rinfret S, Kalavrouziotis D, Johansen H, Behlouli H, Newman A, Pilote L. Cardiovascular outcomes after a change in prescription policy for clopidogrel. N Engl J Med. 2008;359:1802-1810.
11. Makaryus AN, Friedman EA. Patients' understanding of their treatment plans and diagnosis at discharge. Mayo Clin Proc. 2005;80:991-994.
12. Kripalani S, Henderson LE, Jacobson TA, Vaccarino V. Medication use among inner-city patients after hospital discharge: patient-reported barriers and solutions. May Clin Proc. 2008;83:529-535.
13. Garavalia L, Ho M, Garavalia B, Foody J, Kruse H, Spertus J, Decker C. Clinician-patient discord: exploring differences in perspectives for clopidogrel persistence. Eur J Cardiovasc Nursing. 2009;8:S36.
14. Coleman EA, Parry C, Chalmers S, Min SJ. The care transitions intervention: results of a randomized controlled trial. Arch Intern Med. 2006;166:1822-1828.
15. Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, Kachalia A, Horng M, Roy CL, McKean SC, Bates DW. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-571.
16. Aoki J, Lansky AJ, Mehran R, Moses J, Bertrand ME, McLaurin BT, Cox DA, Lincoff AM, Ohman EM, White HD, Parise H, Leon MB, Stone GW. Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy Trial. Circulation. 2009;119:687-698.
17. Diamantopoulos L, Huang Y, Liu X, Li S, Desmet W, Van De Werf F, De Scheerder I. Arterial wall temperature following coronary stent implantation in pigs: the role of post-stent inflammation. J Invasive Cardiol. 2003;15:191-197.